We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Kate C Robins has been assisting clients through the H1B Visa process since 2020.

As of 2022, Kate C Robins has succesfully submitted and recieved certification for 255 cases.

Kate C Robins is located in Boston, MA, and has represented 10 employers for the H1B Visa Process

260
Cases Handled
255
Cases Certified
98.08%
Approval

Cases Handled by Kate C Robins

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23067-833064 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23067-833063 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23067-833062 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23067-833060 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23055-803272 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23003-676807 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-22353-649390 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-22342-630603 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-21274-619110 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics Inc 2022
I-200-21260-592062 Certified Bioinformatics Scientists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics Inc 2021